Did the NYSE just delist Pfizer over the recent release of their COVID-19 vaccine documents?!

Take a look at the viral claim, and find out what the facts really are!

 

Claim : NYSE Just Delisted Pfizer Over Vaccine Scandal!

People are excitedly sharing messages and articles claiming that the New York Stock Exchange (NYSE) just delisted Pfizer over the recent release of their COVID-19 vaccine documents.

Allegedly, this delisting was over 9 pages of Pfizer documents that listed 1,291 side effects from their COMIRNATY mRNA vaccine.

This example of what’s being shared is long, so feel free to skip to the next section for the facts!

 

Truth : NYSE Did NOT Delist Pfizer Over Vaccine Scandal!

This is yet another example of anti-Pfizer, anti-vaccine FAKE NEWS being created and propagated by anti-vaccination activists. Here are the reasons why…

Fact #1 : NYSE Did Not Delist Pfizer

It’s really silly, but let me just say it out straight – the New York Stock Exchange did NOT delist Pfizer.

Anyone who takes just 2 seconds to look at the NYSE website, or even Google, would realise that Pfizer Inc. (PFE) is still listed on the New York Stock Exchange!

Not only is Pfizer still on the NYSE, its stock price actually went up by 2.17% on 11 March 2022!

Read more : Was Pfizer COVID-19 Vaccine Proven To Change Our DNA?!

Fact #2 : Pfizer Delisted Its 0.250% Note From NYSE

People are sharing this Form 25 document filed with the SEC (US Securities and Exchange Commission) on 7 March 2022, as evidence that Pfizer was delisted from the NYSE.

The trouble is the Form 25 does not say what they think it said. The Form 25 was not filed to delist Pfizer from the NYSE.

Instead, Pfizer filed that Form 25 to delist its euro-denominated 0.250% notes – basically debt with a payable interest of 0.25% that matured on 7 March 2022.

In short, Pfizer paid off that matured debt with interest, and consequently removed the notes from the NYSE.

It’s even stated in the description of their 7 March 2022 SEC filing on the Pfizer website.

With the delisting of the 0.250% note, only the Pfizer common stock (PFE) and their 1.000% Note are still listed on the NYSE.

Fact #3 : Pfizer Vaccine Not Linked To 1,291 Adverse Events

The articles and messages falsely claimed that the Pfizer-BioNTech COVID-19 vaccine was linked to 1,291 adverse events in the recently-released documents.

That is a gross / intentional misunderstanding of the “List of Adverse Events of Special Interest” (AESI) in one of the documents released by the FDA.

That was a list of potential adverse events that Pfizer would looking out for in their post-vaccination surveillance.

Think of it as a shopping list of adverse events that everyone agreed that Pfizer should be looking out for.

Even if these adverse events did occur, scientists still need to find out if they actually occurred because of the vaccine, or some other causes.

Read more : Did Pfizer Vaccine Documents Reveal 1,291 Side Effects?!

Fact #4 : BioNTech Is Much Smaller Than Pfizer

Whoever wrote that piece is an idiot. A 5 second search would have shown the writer that BioNTech is much… MUCH smaller than Pfizer.

As of 13 March 2022, BioNTech has a market capitalisation of 32.9 billion dollars, while Pfizer is valued at 282.7 billion dollars. In other words, Pfizer is 8.6X “larger” than BioNTech.

While it is technically possible for BioNTech to buy out Pfizer, it would require A LOT of funds, many times more than it is worth. It is far more likely for Pfizer to buy BioNTech.

Fact #5 : Pfizer Acquired Arena Pharmaceuticals That Day

Ironically, Pfizer completed its acquisition of Arena Pharmaceuticals on 11 March 2022 – the day it was claimed that Pfizer was delisted from the NYSE.

Instead of Pfizer being delisted from the NYSE, it was Arena Pharmaceuticals that was delisted from the NASDAQ Global Select Market.

Incidentally, Pfizer purchased Arena for approximately $6.7 billion. While that’s a huge amount of money to most of us, it’s just 2.37% of Pfizer’s market capitalisation.

Fact #6 : Company Acquisitions Do Not Necessarily Change Products

The writer wonders what (vaccine) formula will BioNTech use after they acquire Pfizer. That’s an incredibly stupid comment.

First of all, the COMIRNATY vaccine was developed by BioNTech, not Pfizer. Pfizer is merely their manufacturing and marketing partner, just like Fosun Pharma in China. The vaccine technology and rights belong to BioNTech, not Pfizer.

Secondly, just because a company is acquired does not mean the new owners have to change product formulas, especially if it’s a winner like the COMIRNATY vaccine.

Fact #7 : Vaccines Are Highly Regulated

Unlike consumer products like Coca-Cola, vaccines are highly-regulated.

While you can buy over The Coca-Cola Company, and change the drink’s formula on a whim; changing the vaccine formula will mean new clinical trials and a new approval process.

And consider the absurdity of BioNTech buying over Pfizer, merely to change its own formula? This logic pretzel is simply astounding.

 

 

Recommended Reading

• Did Putin Just Threaten To Release 9/11 Satellite Evidence?!
• Are 90% of COVID-19 Deaths in England Fully-Vaccinated?!
• Did Putin Humiliate Japan With His American Dog?!
• Did Pfizer Vaccine Documents Reveal 1,291 Side Effects?!
• Reiner Fuellmich COVID-19 Grand Jury Video Fact Checked!

Go Back To > Business | Fact Check | Tech ARP

 

Support Tech ARP!

Please support us by visiting our sponsors, participating in the Tech ARP Forums, or donating to our fund. Thank you!